Neuland Laboratories Ltd 524558
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹11,982.50
- Day Range
- ₹11,819.10–12,452.70
- 52-Week Range
- ₹3,612.05–13,600.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹155.37 Bil
- Volume/Avg
- 671 / 4,502
Key Statistics
- Price/Earnings (Normalized)
- 48.82
- Price/Sales
- 9.76
- Dividend Yield (Trailing)
- 0.12%
- Dividend Yield (Forward)
- 0.12%
- Total Yield
- 0.12%
Company Profile
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,855
- Website
- https://www.neulandlabs.com
Comparables
Valuation
|
Metric
|
524558
|
512529
|
532482
|
|---|---|---|---|
Price/Earnings (Normalized) | 48.82 | 228.00 | 27.60 |
Price/Book Value | 12.11 | 8.92 | 4.30 |
Price/Sales | 9.76 | 3.65 | 2.95 |
Price/Cash Flow | 45.99 | 167.73 | 23.68 |
Price/Earnings
524558
512529
532482
Financial Strength
|
Metric
|
524558
|
512529
|
532482
|
|---|---|---|---|
Quick Ratio | 1.14 | 0.65 | 0.66 |
Current Ratio | 2.15 | 1.31 | 1.40 |
Interest Coverage | 39.15 | 1.24 | 9.65 |
Quick Ratio
524558
512529
532482
Profitability
|
Metric
|
524558
|
512529
|
532482
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
524558
512529
532482
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rqmzjwtjq | Bdjx | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Rmvxdsfkk | Wmbhsmh | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Thbzpvsg | Wqxw | $46.6 Bil | |||
| Viatris Inc
VTRS
| Ngtzpqgp | Gtxl | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fntvxfcl | Lglb | $13.2 Bil | |||
| Catalent Inc
CTLT
| Qvkjcvtww | Tywqrtj | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tnycxqttw | Ptphbb | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Qvrxdlwk | Tjj | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Zjgqpmcqz | Zmqb | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tmvgfjdb | Rpdj | $2.2 Bil |
United States